Value of first day angiography/angioplasty in evolving non-ST segment elevation myocardial infarction: An open multicenter randomized trial: The VINO study

European Heart Journal

Volumn 23, Issue 3, 2002, Pages 230-238

  Spacek R ^a   Widimsky P ^a   Straka, Z ^a   Jiresova E ^a   Dvorak J ^a   Polasek R ^a   Karel, I ^a   Jirmar R ^a   Lisa, L ^a   Budesinsky, T ^a   Malek F ^a   Stanka, P ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acute coronary syndromes; Coronary angioplasty; Coronary artery bypass grafting; Early invasive treatment strategy; Non ST segment elevation myocardial infarction

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ANGIOPLASTY; ARTICLE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DILATATION; CORONARY REPERFUSION; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART INFARCTION; HEART REINFARCTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; MORTALITY; MULTICENTER STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; THORAX PAIN; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY ARTERY BYPASS; ELECTROCARDIOGRAPHY; ENDPOINT DETERMINATION; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0036488048     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2735     Document Type: Article

References (57)

1. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-82.
2. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-4.
3. Stone GW, Brodies BR, Griffin JJ et al. for the Primary Angioplasty in Myocardial Infarction (PAMI) Stent Pilot Trial Investigators. Prospective, multicenter study of the safety and feasibility of primary stenting in acute myocardial infarction: in-hospital and 30-day results of the PAMI Stent Pilot Trial. J Am Coll Cardiol 1998; 31: 23-30.
4. Suryapranata H, van't Hof AWJ, Hoornje JCA, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502-5; N Engl J Med 1993; 329: 673-82.
5. Suryapranata H, van't Hof AWJ, Hoornje JCA, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97: 2502-5; N Engl J Med 1993; 329: 673-82.
6. Widimský P, Groch L, Želízko M, Aschermann M, Bednář F, Suryapranata H. Multicenter randomized trial comparing transport to primary angioplasty versus immediate thrombolysis versus combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE Study. Eur Heart J 2000; 21: 823-31.
7. Phibbs B, Marcus F, Marriott HJ, Moss A, Spodick DH. Q-wave versus non-Q wave myocardial infarction: a meaningless distinction. J Am Coll Cardiol 1999; 33: 576-82.
8. Karlsson JE, Berglund U, Bjorkholm A, Ohlsson J, Swahn E, Wallentin L. Thrombolysis with recombinant human tissuetype plasminogen activator during instability in coronary artery disease: Effect on myocardial ischemia and need for coronary revascularization. Am Heart J 1992; 124: 1419-26.
9. The TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB trial. Circulation 1994; 89: 1545-56.
10. Ambose JA, Sharma SK, Almeida OD, et al. Paradoxical increase in ischemic complication with prophylactic urokinase in unstable angina - (TAUSA) trial. Circulation 1993; 88: 1-608.
11. Boden WE, O'Rourke RA, Crawford MH et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. N Engl J Med 1998; 338: 1785-92.
12. Campbell RWF, Wallentin L, Verheugt FWA et al. Management strategies for a better outcome in unstable coronary artery disease. Clin Cardiol 1998; 21: 314-22
13. Hillis WS. The continuing debate: conservative or interventional therapy for unstable coronary artery disease. Am J Cardiol 1997; 80: 51E-54E
14. Chung MK, Bosner MS, McKenzie JP, Shen J, Rich MW. Prognosis of patients = 70 years of age with non-Q-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients or = 70 years of age with Q-wave acute myocardial infarction. Am J Cardiol 1995; 75: 18-22.
15. Stone PH, Thompson B, Anderson HV et al. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: The TIMI registry. JAMA 1996; 275: 1104-12.
16. Viecili PN, Leite PF, Pamplona D et al. Prognostic value of admission electrocardiogram of 1072 patients with unstable angina and non Q wave myocardial infarction. J Am Coll Cardiol 1999; 33: 359A.
17. Cannon CP, McCabe Ch, Stone PH et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia. J Am Coll Cardiol 1997; 30: 133-40.
18. Schechtman KB, Capone RJ, Kleiger RE et al. Risk Stratification of patients with non-Q wave myocardial infarction. The role of ST segment depression. The Diltiazem Reinfarction Study Research Group. Circulation 1989; 80: 1148-58.
19. Krone RJ, Greenberg H, Dwyer EM Jr, Kleiger RE, Boden WE. Long-term prognostic significance of ST segment depression during acute myocardial infarction. The Multicenter Dilthiazem Postinfarction Trial research Group. J Am Coll Cardiol 1993; 22: 361-7.
20. Haim M, Hod H, Reisin L et al. Comparison of short- and long-term prognosis in patients with anterior wall versus inferior or lateral wall non-Q wave acute myocardial infarction. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT) Study Group. Am J Cardiol 1997; 79: 717-21.
21. Kao W, Khaja F, Goldstein S, Gheorghiade M. Cardiac event rate after non-Q wave acute myocardial infarction and the significance of its anterior location. Am J Cardiol 1989; 71: 1236-42.
22. Welty FK, Mittelman MA, Lewis SM, Healy RW, Shubrooks SJ, Muller JE. Significance of location (anterior versus inferior) and type (Q-wave versus non-Q-wave) of acute myocardial infarction in patients undergoing percutaneous transluminal coronary angioplasty for postinfarction ischemia. Am J Cardiol 1995; 76: 431-5.
23. Kleinman NS, Anderson HV, Rogers WJ, Theroux P, Thompson B, Stone PH. Comparison of outcome of patients with unstable angina and non-Q-wave acute myocardial infarction with and without prior coronary artery bypass grafting (Thrombolysis on Myocardial Ischemia III Registry). Am J Coll Cardiol 1996; 77: 227-31.
24. Tocchi M, Rosanio S, Penco M et al. Prognostic significance of left ventricular hyperthrophy assessed by echocardiography in non-Q-wave myocardial infarction. J Am Coll Cardiol 1999; 33: 333A.
25. Burns M, Lambrew C, Every N et al. for the NRMI-2 Investigators. Identification of patients with non-ST segment elevation myocardial infarction at risk for adverse clinical outcomes: A validated model from the National Registry of Myocardial Infarction-2 Database. J Am Coll Cardiol 1999; 33: 359A.
26. Krone RJ, Dwyer IM Jr, Greenberg H et al. Risk stratification in patients with first non-Q wave infarction: limited value of early low level exercise test after uncomplicated infarcts. The Multicenter Post-Infarction Group. J Am Coll Cardiol 1989; 14: 31.
27. Varma SK, Gibson RS. Predischarge exercise ECG vs thallium 201 in predicting prognosis after non-Q-wave myocardial infarction (abstract). Circulation 1987; 76 (Suppl 4): 157.
28. Wang CH, Cheng WJ, Hua CC et al. Prognostic value of dobutamine echocardiography in patients after Q-wave myocardial infarction or non-Q-wave acute myocardial infarction. Am J Cardiol 1998; 82: 38-42.
29. The GISSI-3 APPI Study Group. Early and six-month outcome in patients with angina pectoris early after acute myocardial infarction. Am J Cardiol 1996; 78: 1191-7.
30. Shaw LJ, Peterson ED, Kesler K, Hasselblad V, Califf RM. A Metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996; 78: 1327-37.
31. Farrell TG, Odemugiwa O, Bashir Y et al. Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. Br Heart J 1992; 67: 129.
32. La Rovere M, Bigger JT, Marcus FI et al. for the ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Baroreceptor sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. Lancet 1998; 351: 478.
33. Fox KAA, Cokkinos DV, Deckers J, Keil U, Maggioni A, Steg G on behalf of th ENACT (European Network for Acute Coronary Treatment) investigators. The ENACT study: a pan-European survey of acute coronary syndromes. Eur Heart J 2000; 21: 1440-9.
34. Liebson PR, Klein LW. The non-Q wave myocardial infarction revisited: 10 years later. Prog Cardiovasc Dis 1997; 39: 399-444.
35. Karlson BW, Herlitz J, Richtez A, Hjalmarson A. Prognosis in acute myocardial infarction in relation to development of Q-waves. Clin Cardiol 1991; 14: 875-80,
36. Goodman SG, Langer A, Ross AM et al. Non-Q-wave versus Q-wave myocardial infarction after thrombolytic therapy: angiographic and prognostic insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries-I angiographic substudy. GUSTO-I Angiographic Investigators. Circulation 1998; 97: 444-50.
37. Peterson ED, Shaw LJ, Califf RM. Risk stratification after myocardial infarction. Ann Intern Med 1997; 126: 561-82.
38. William EB. Non-Q-wave myocardial infarction: a prognostic paradox. Hosp Pract 1992; 27: 129-33.
39. Nixon JV. Non-Q-wave myocardial infarction. An incomplete cardiac event requiring an aggressive approach. Postgrad Med 1994; 95: 211-23.
40. Wang CH, Cherng WJ, Hua CC, Hung MJ. Prognostic value of dobutamine echocardiography in patients after Q-wave or non-Q wave acute myocardial infarction. Am J Cardiol 1998; 82: 38-42.
41. Behar S, Haim M, Hod H et al. Long-term prognosis of patients after a Q wave compared with non-Q wave first acute myocardial infarction. Data from SPRINT Registry. Eur Heart J 1996; 17: 1532-7.
42. Haim M, Gottlieb S, Hod H, Behar S. The prognosis of patients with a first non-Q-wave acute myocardial infarction in the pre and thrombolytic eras. J Am Coll Cardiol 1999; 33: 332A.
43. Zaacks ZM, Liebson PR, Calvin JE, Parrillo JE, Klein LW. Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? J Am Coll Cardiol 1999; 33: 107-18.
44. De Wood MA, Stifter WF, Simpson CS et al. Coronary arteriographic findings soon after non-Q-wave myocardial infarction. N Engl Med 1986; 315: 417-23.
45. Bertrand ME, Simoons ML, Fox KAA et al. Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology. Eur. Heart J 2000; 21: 1406-32.
46. Ryan TJ, Antman EM, Brooks NH et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infartion. A report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999; 34: 890-911.
47. Anderson HV, Cannon CP, Stone PH et al. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction. J Am Coll Cardiol 1995; 26: 1643-50.
48. Wallentin L, Lagerqvist B, Husted S, Kontny F, Stahle E, Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease. Lancet 2000; 356: 9-16.
49. Braxton JH, Hammond GL, Letsou GV et al. Optimal timing of coronary artery bypass graft surgery after acute myocardial infarction. Circulation 1995; 92 (9 Suppl): 66-8.
50. Scull GS, Martin JS, Weaver WD, Every NR for the MITI Investigators. Early angiography versus conservative treatment in patients with non-st elevation acute myocardial infarction. J Am Coll Cardiol 2000; 35: 895-902.
51. Cannon CP, Weintraub WS, Demopoulos LA, Robertson DH, Gormley GJ, Braunwald E. Invasive versus conservative strategies in unstable angina and non-Q wave myocardial infarction following treatment with tirofiban: rationale and study design of the international TACTICS-TIMI 18 Trial. Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy. Thrombolysis in Myocardial Infarction. Am J Cardiol 1998; 82: 731-6.
52. Cannon CP. Treat angina with aggrastat+determine cost of therapy with an invasive or conservative strategy. TACTICS-TIMI 18. American Heart Association Scientific Session 2000, New Orleans.
53. Simoons M et al. GUSTO IV-ACS Study. In: CD ROM 'Highlights from the XXIInd Congress of the European Society of Cardiology', Amsterdam, Prous Science, 2000.
54. EPISTENT Investigators. Evaluation of Platelet IIb/IIIa Inhibitor for Stenting. Lancet 1999; 354: 2019-24 .
55. PRISM-PLUS Study Investigators. Inhibition of platelet glycoprotein IIb/IIIa receptor with Tirofiban in unstable angina and non-Q wave myocardial infarction. N Engl J Med 1998; 338: 1488-97.
56. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998; 339: 436-43.
57. Topol EJ, Mark DB, Lincoff AM et al. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/ IIIablockade in patients undergoing coronary stenting: results from a multicentre randomised trial. Lancet 1999; 354: 2019-24 .